Financials

  • Market Capitalization 73.28 M
  • Employee 7
  • Founded 2008
  • CEO Maria-luisa Maccecchini
  • Website www.annovisbio.com
  • Headquarter Delaware, United States
  • FIGI BBG00PN9XD40
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4092
NRXS
Neuraxis, Inc. Common Stock
5.97 USD-1.32%-3.24%-0.67%+9.94%74.97 M USD
4094
ELTX
Elicio Therapeutics, Inc. - Common Stock
2.84 USD-5.33%-7.19%-2.74%-71.60%74.64 M USD
4107
CRDF
Cardiff Oncology, Inc. - Common Stock
0.94 USD-5.05%+1.08%+18.99%-54.81%73.13 M USD
4116
MNOV
MediciNova, Inc. - Common Stock
1.44 USD+1.41%+3.60%+9.09%+10.77%70.88 M USD

Frequently asked questions about Annovis Bio, Inc.

What is the Annovis Bio, Inc. stock price today?

The current price of Annovis Bio, Inc. (ANVS) is 1.72. Over the past 24 hours, the stock has changed by -4.97%. Follow the ANVS chart for real-time price dynamics.

What is the stock ticker of Annovis Bio, Inc.?

Annovis Bio, Inc. trades under the ticker ANVS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Annovis Bio, Inc. stock going up?

ANVS has changed by -6.01% over the last week, -2.27% over the last month, and -25.54% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Annovis Bio, Inc.?

Annovis Bio, Inc. currently has a market capitalization of 73.28 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Annovis Bio, Inc. earnings last quarter?

Last quarter, Annovis Bio, Inc. reported earnings of -0.4 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Annovis Bio, Inc. revenue for the last quarter?

Annovis Bio, Inc. reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Annovis Bio, Inc. net income for the last quarter?

Annovis Bio, Inc. reported net income of -14.82 M for the last quarter. The previous quarter showed -17.61 M, which means net income changed by +15.82%.

How many employees does Annovis Bio, Inc. have?

As of the latest available data, Annovis Bio, Inc. has 7 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Annovis Bio, Inc. stock?

You can buy Annovis Bio, Inc. (ANVS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Annovis Bio, Inc. stock?

Investing in Annovis Bio, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ANVS chart and related analysis on metatrader.com as part of your research.

News